Clinical trial
Budesonide Treatment for Lymphocytic Colitis
NCT00180050 · Technische Universität Dresden, Other · Completed
Key facts
| NCT number | NCT00180050 |
|---|---|
| Title | Budesonide Treatment for Lymphocytic Colitis |
| Official title | Efficacy and Safety of Budesonide for Treatment of Lymphocytic Colitis |
| Lead sponsor | Technische Universität Dresden, Other |
| Collaborators | Dr. Falk Pharma GmbH Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Microscopic Colitis |
| Intervention type | Drug |
| Interventions | Budesonide |
| Enrollment | 40 |
| Start date | Jan 1, 2002 |
| Primary completion | Aug 1, 2006 |
| Completion | Aug 1, 2007 |
| First posted | Sep 16, 2005 |
| Last update posted | Mar 30, 2010 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: